$AURX Nuo Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nuo Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Nuo Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Nuo Therapeutics, Inc. for free.
IRS Number: 233011702
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: AURX
Company Address: 209 PERRY PARKWAY, SUITE 7 GAITHERSBURG, 20877
Phone number: 240-499-2680
Former name: AUTOLOGOUS WOUND THERAPY INC, date of change: 2000-04-07
Former name: AUTOLOGOUS WOUND THERAPY INC, date of change: 2000-04-07
Former name: CYTOMEDIX INC, date of change: 2000-05-11
Former name: Nuo Therapeutics, Inc, date of change: 2014-11-12
Former name: Informatix Holdings, Inc.
Market Capitalization: $1.82M
Prev close: $0.01
Average Daily Volume: 558,545
Days Low: $0.00
Year Low: $0.01
Year High: $0.33
Nuo Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 03 2019 | AURX | Nuo Therapeutics, ... | Atinsky Lawrence | Director | Option Exercise | A | 0.40 | 62,500 | 25,000 | 62,500 | |
| Jan 03 2019 | AURX | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Option Exercise | A | 0.40 | 125,000 | 50,000 | 125,000 | |
| Jan 03 2019 | AURX | Nuo Therapeutics, ... | Mintz Paul | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
| Jan 03 2019 | AURX | Nuo Therapeutics, ... | Pittman Scott M. | Director | Option Exercise | A | 0.40 | 62,500 | 25,000 | 62,500 | |
| Jan 03 2019 | AURX | Nuo Therapeutics, ... | CLAUSEN PETER | CSO | Option Exercise | A | 0.40 | 81,250 | 32,500 | 81,250 | |
| Jan 03 2019 | AURX | Nuo Therapeutics, ... | WINZER C ERIC | Director | Option Exercise | A | 0.40 | 68,750 | 27,500 | 68,750 | |
| Aug 13 2018 | AURX | Nuo Therapeutics, ... | Pittman Scott M. | Director | Option Exercise | A | 0.40 | 121,875 | 48,750 | 121,875 | |
| Aug 13 2018 | AURX | Nuo Therapeutics, ... | Atinsky Lawrence | Director | Option Exercise | A | 0.40 | 109,375 | 43,750 | 109,375 | |
| Aug 13 2018 | AURX | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Option Exercise | A | 0.40 | 192,710 | 77,084 | 192,710 | |
| Aug 13 2018 | AURX | Nuo Therapeutics, ... | WINZER C ERIC | Director | Option Exercise | A | 0.40 | 120,313 | 48,125 | 120,313 | |
| Aug 13 2018 | AURX | Nuo Therapeutics, ... | CLAUSEN PETER | CSO | Option Exercise | A | 0.40 | 183,853 | 73,541 | 183,853 | |
| Aug 13 2018 | AURX | Nuo Therapeutics, ... | Mintz Paul | Director | Option Exercise | A | 0.40 | 87,500 | 35,000 | 87,500 | |
| Sep 21 2017 | NUOT | Nuo Therapeutics, ... | Boyalife Investment Fund I, In ... | 10% Owner | Buy | P | 0.22 | 3,150,000 | 699,930 | 4,900,000 | 1.8 M to 4.9 M (+180.00 %) |
| Aug 14 2017 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Buy | P | 0.22 | 247,500 | 54,995 | 557,146 | 309.6 K to 557.1 K (+79.93 %) |
| Aug 14 2017 | NUOT | Nuo Therapeutics, ... | Pittman Scott M. | Director | Buy | P | 0.50 | 560,000 | 280,000 | 2,935,800 | 2.4 M to 2.9 M (+23.57 %) |